A/s Novo, 10% Owner at Tibira Therapeutics, Inc. (TBRA), bought 838,041 shares at $10.62 ($8.9M) on 2015-05-04, disclosed to the SEC on 2015-05-06.
Open-market purchase of $8.9M TBRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| RETA | SELL | 2017-06-12 | $5.7M | — | Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $590K | — | Filing → |